Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

No single treatment for androgenetic alopecia exists, but available options are generally satisfying.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

AUC and APL are distinct conditions needing careful clinical assessment.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Combining PRP with other treatments can improve hair loss outcomes.

People with moderate or severe hair loss have higher death rates from diabetes and heart disease.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

The document concluded that home treatments are needed for hair loss control, but professionals should better understand how these treatments work.

People with androgenetic alopecia may have a higher genetic risk for cardiovascular diseases.

Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Treat hair loss with medicine, continue indefinitely.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Androgenetic alopecia is influenced by age, occupation, education, mental health, genetics, and diet, and psychological treatment is important.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

PRP is a promising treatment for hair loss.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Androgens might not be the only major factor in hair loss; other elements could also be important.

Lasers and energy-based devices effectively and safely improve hair growth in androgenetic alopecia, especially when combined with other treatments.

Male hair loss is caused by inactive hair follicle stem cells.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Hair loss gene linked to prostate issues.

Hair loss link to severe COVID-19 unclear.